News & Trends - Pharmaceuticals
Finalists announced for Health Industry Hub’s Catalysts for Change Awards 2022
Universal healthcare is one of the cornerstones of the Australian way of life. It’s built on the principle that every Australian should have equal access to quality healthcare based on medical need – not the size of their wallets, their postcode or ethnicity.
Although the issue of health equity has existed long before the emergence of COVID-19, the pandemic brought attention to the challenges, amplifying the profound impact that social, economic and environmental factors have on our health and wellbeing.
2022 Catalysts for Change Awards
In recognising and celebrating the most relevant industry leader perspectives and the brightest minds that inspire us to take bold action in making meaningful change, Health Industry Hub is thrilled to announce the finalists for the 2022 Catalysts for Change Awards.
The awards recognise the MOST VIEWED webinars and TOP podcasts with leaders and change makers that have been accessed by our subscribers across the Pharma, MedTech and Biotech sectors.
The high level of engagement indicates a strong appetite for industry professionals to connect with like-minded learners, challenge the status quo and develop future-ready strategies to build better selves and better communities.
Most Viewed Webinars and Top Podcasts
The finalists* for the 2022 Catalysts for Change Awards (in no particular order) are:
News & Trends Category
- Cardinal Health: Top trends shifting the future of the medtech sector – Cardinal Health global leader
- Merck Healthcare: Merck Healthcare MD talks key trends impacting the equity of access to infertility care
- Patient Voice Initiative: Patient advocacy group sets sights on future of interactions with industry
- AbbVie: Reform is the main game for improvement, says AbbVie’s Chris Stemple
- Pathology Awareness Australia/Abbott: Leveraging molecular diagnostics and digital pathology to strengthen value of sector: Pathology Awareness Australia
- Medical Technology Association of Australia (MTAA): APHA and CHF recognise medtech commitment to Prostheses List agreement but focus must ‘switch to true reforms’ of private health insurance
Leadership Category
- Gilead: Gilead GM talks gender equity and future work trends in the pharma industry
- Noxopharm: New Noxopharm CEO has her eyes firmly set on the future
- Bristol Myers Squibb: Men must step up and drive gender equity at home and in the workplace, says BMS leader
- Roche Diagnostics: How to achieve equity in diagnostic excellence, Roche Diagnostics MD
- Johnson & Johnson MedTech: The state of gender equity in surgery is much more than numbers
- Australian Orthopaedic Association: First female AOA President to lead a new era in orthopaedics
Digital & Innovation Category
- Pfizer: Pfizer strengthens position to ‘win the digital race in pharma’
- Medtronic: Medtronic VP talks the rise of health technology and key trends driving the innovation ecosystem
- AstraZeneca: AstraZeneca-UNSW partner to boost the Australian startup ecosystem
- Philips: Philips leader talks virtual care as key to a consumer centric future of health
- AbbVie: Purposeful innovation a must in enhancing customer experience, says AbbVie’s Strategy and Innovation Leader
Human Resources Category
- Sanofi & Cardinal Health: HR leaders from Sanofi and Cardinal Health reveal the future of work in the pharma and medtech sectors
- Organon: Integrated employee wellbeing: The key to success in the future of work
- Pharma Australia Inclusion Group (PAIG): PAIG co-chairs shed a light on the need to link diversity and inclusion to business performance
- Viatris: Viatris and Canteen partner to close mental health care gap for young cancer patients and bring ‘meaning’ to everyday work
- Paras and Partners & Hunton Executive: Talent acquisition and retention: The current state of play
- ARCS: ARCS CEO reveals critical gaps in workforce and capability in pharma, medtech and biotech sectors
Medical Category
- hearts4heart: Tackling change in heart failure management: hearts4heart CEO and expert cardiologist talk the essentials in Heart Failure Awareness Week
- International Medical Robotics Academy (IMRA): Advances in robotics surgery to pave the way for wider access, says Professor Tony Costello
- Medical Affairs Professionals of Australasia (MAPA, previously APPA): APPA leaders have their eyes firmly set on the future of Medical Affairs
- Sanofi: Sanofi medical leader highlights the significance of multiple stakeholder voices in the HTA review
- Research Australia: We must understand what we’re funding if we are to support a sustainable research ecosystem
- GenesisCare: GenesisCare to drive new models of care in navigating the complex oncology landscape
The winners of the 2022 Catalysts for Change Awards will be announced on Monday 12th December!
Here’s our WHY. What’s yours?
As the first female founder of healthcare industry media, Rozalina’s passion for health and gender equity stems from her own lived experiences as a first generation Australian who escaped war and came to this beautiful country as a refugee.
Born from 20 years of working and leading in the pharma and diagnostics sectors, Health Industry Hub is the only one-stop-hub bringing the diversity of the Pharma, MedTech & Biotech sectors together to inspire innovation and collaboration in driving positive changes in healthcare.
We empower the career and leadership journey of industry professionals who seek to reach their highest potential and bring forth bold action in making meaningful change – personally and professionally.
*Finalists are based on Health Industry Hub analytics and engagement from 1 December 2021 – 30 November 2022
News & Trends - Pharmaceuticals
March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions
The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]
MoreNews & Trends - MedTech & Diagnostics
J&J MedTech exits DePuy Synthes spine portfolio
Johnson & Johnson MedTech will officially exit the DePuy Synthes Spine portfolio in Australia tomorrow, November 30, as part of […]
MoreNews & Trends - Pharmaceuticals
Home-grown hypertension polypill heads to regulatory approval
Australian-supported research has revealed remarkable Phase III clinical trial results for an innovative triple drug combination in the treatment of […]
MoreNews & Trends - Pharmaceuticals
Will Australia become first country to eliminate HIV transmission by 2030?
In the lead-up to World AIDS Day on December 1, the Albanese Government has unveiled the 9th National HIV Strategy, […]
More